Hennink WE - Search Results

1

Optimization of intradermal vaccination by DNA tattooing in human skin.

van den Berg JH, Nujien B, Beijnen JH, Vincent A, van Tinteren H, Kluge J, Woerdeman LA, Hennink WE, Storm G, Schumacher TN, Haanen JB. van den Berg JH, et al. Among authors: hennink we. Hum Gene Ther. 2009 Mar;20(3):181-9. doi: 10.1089/hum.2008.073. Hum Gene Ther. 2009. PMID: 19301471 Free PMC article.

2

Comparative transfection studies of human ovarian carcinoma cells in vitro, ex vivo and in vivo with poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes.

van de Wetering P, Schuurmans-Nieuwenbroek NM, Hennink WE, Storm G. van de Wetering P, et al. Among authors: hennink we. J Gene Med. 1999 May-Jun;1(3):156-65. doi: 10.1002/(SICI)1521-2254(199905/06)1:3<156::AID-JGM29>3.0.CO;2-O. J Gene Med. 1999. PMID: 10738564

3

Cationic polymeric gene delivery of beta-glucuronidase for doxorubicin prodrug therapy.

Fonseca MJ, Storm G, Hennink WE, Gerritsen WR, Haisma HJ. Fonseca MJ, et al. Among authors: hennink we. J Gene Med. 1999 Nov-Dec;1(6):407-14. doi: 10.1002/(SICI)1521-2254(199911/12)1:6<407::AID-JGM71>3.0.CO;2-Q. J Gene Med. 1999. PMID: 10753066

4

Effects of physicochemical characteristics of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes on cellular association and internalization.

Zuidam NJ, Posthuma G, de Vries ET, Crommelin DJ, Hennink WE, Storm G. Zuidam NJ, et al. Among authors: hennink we. J Drug Target. 2000;8(1):51-66. doi: 10.3109/10611860009009209. J Drug Target. 2000. PMID: 10761645

5

Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells.

Mastrobattista E, Kapel RH, Eggenhuisen MH, Roholl PJ, Crommelin DJ, Hennink WE, Storm G. Mastrobattista E, et al. Among authors: hennink we. Cancer Gene Ther. 2001 Jun;8(6):405-13. doi: 10.1038/sj.cgt.7700311. Cancer Gene Ther. 2001. PMID: 11498760

6

Nanotechnological approaches for the delivery of macromolecules.

Crommelin DJ, Storm G, Jiskoot W, Stenekes R, Mastrobattista E, Hennink WE. Crommelin DJ, et al. Among authors: hennink we. J Control Release. 2003 Feb 21;87(1-3):81-8. doi: 10.1016/s0168-3659(03)00014-2. J Control Release. 2003. PMID: 12618025 Review.

7

Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes.

van Steenis JH, van Maarseveen EM, Verbaan FJ, Verrijk R, Crommelin DJ, Storm G, Hennink WE. van Steenis JH, et al. Among authors: hennink we. J Control Release. 2003 Feb 21;87(1-3):167-76. doi: 10.1016/s0168-3659(02)00361-9. J Control Release. 2003. PMID: 12618033

8

Shifting paradigms: biopharmaceuticals versus low molecular weight drugs.

Crommelin DJ, Storm G, Verrijk R, de Leede L, Jiskoot W, Hennink WE. Crommelin DJ, et al. Among authors: hennink we. Int J Pharm. 2003 Nov 6;266(1-2):3-16. doi: 10.1016/s0378-5173(03)00376-4. Int J Pharm. 2003. PMID: 14559389 Review.

9

Intravenous fate of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes.

Verbaan F, van Dam I, Takakura Y, Hashida M, Hennink W, Storm G, Oussoren C. Verbaan F, et al. Eur J Pharm Sci. 2003 Dec;20(4-5):419-27. doi: 10.1016/j.ejps.2003.09.005. Eur J Pharm Sci. 2003. PMID: 14659486

10

Steric stabilization of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes mediates prolonged circulation and tumor targeting in mice.

Verbaan FJ, Oussoren C, Snel CJ, Crommelin DJ, Hennink WE, Storm G. Verbaan FJ, et al. Among authors: hennink we. J Gene Med. 2004 Jan;6(1):64-75. doi: 10.1002/jgm.475. J Gene Med. 2004. PMID: 14716678

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

567 results

Search Page

Filters